Quadrant Capital Group’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,647
Closed -$102K 2029
2026
Q1
$102K Sell
6,647
-149
-2% -$2.48K ﹤0.01% 1475
2025
Q4
$123K Sell
6,796
-235
-3% -$4.04K ﹤0.01% 1443
2025
Q3
$113K Buy
+7,031
New +$103K ﹤0.01% 1447
2025
Q2
Sell
-6,532
Closed -$81.5K 2088
2025
Q1
$81.5K Buy
6,532
+36
+0.6% +$593 ﹤0.01% 1588
2024
Q4
$129K Buy
6,496
+1,891
+41% +$20.9K 0.01% 921
2024
Q3
$37.6K Sell
4,605
-1,288
-22% -$8.74K ﹤0.01% 1600
2024
Q2
$40.1K Buy
+5,893
New +$40.3K ﹤0.01% 1516
2023
Q4
Sell
-1,618
Closed -$3.98K 2748
2023
Q3
$3.98K Sell
1,618
-4,234
-72% -$20.2K ﹤0.01% 2230
2023
Q2
$45.8K Buy
5,852
+2,524
+76% +$18K ﹤0.01% 1308
2023
Q1
$21.9K Buy
3,328
+50
+2% +$331 ﹤0.01% 1654
2022
Q4
$19.1K Buy
3,278
+2,831
+633% +$17.7K ﹤0.01% 1681
2022
Q3
$2K Sell
447
-753
-63% -$4.55K ﹤0.01% 2393
2022
Q2
$5K Buy
1,200
+893
+291% +$6.15K ﹤0.01% 1967
2022
Q1
$3K Buy
307
+258
+527% +$2.19K ﹤0.01% 2069
2021
Q4
$0 Sell
49
-130
-73% -$1.51K ﹤0.01% 2627
2021
Q3
$2K Sell
179
-703
-80% -$9.76K ﹤0.01% 2164
2021
Q2
$13K Buy
882
+854
+3,050% +$13.4K ﹤0.01% 1441
2021
Q1
$0 Buy
+28
New +$529 ﹤0.01% 2426

Other funds holding MESO

Quadrant Capital Group's MESO Position: Q2 2026 in Review

Quadrant Capital Group sold out of Mesoblast (MESO) in Q2 2026, closing a stake of 6,647 shares — an estimated $102K sold.

Quadrant Capital Group first reported a position in MESO in Q1 2021 and held it in 18 quarters. The position peaked at $129K in Q4 2024. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • Quadrant Capital Group reported no remaining Mesoblast position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 6,647 Mesoblast shares in Q2 2026, an estimated $102K.
  • Quadrant Capital Group first reported a position in Mesoblast in Q1 2021 and held it in 18 quarters.
  • Quadrant Capital Group's Mesoblast position peaked at $129K in Q4 2024.
  • 72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.